Integration of Chemical and RNAi Multiparametric Profiles Identifies Triggers of Intracellular Mycobacterial Killing  by Sundaramurthy, Varadharajan et al.
Cell Host & Microbe
ArticleIntegration of Chemical and RNAi
Multiparametric Profiles Identifies
Triggers of Intracellular Mycobacterial Killing
Varadharajan Sundaramurthy,1 Rico Barsacchi,1 Nikolay Samusik,1 Giovanni Marsico,1 Jerome Gilleron,1
Inna Kalaidzidis,1 Felix Meyenhofer,1 Marc Bickle,1 Yannis Kalaidzidis,1,2 and Marino Zerial1,*
1Max-Planck Institute of Molecular Cell Biology and Genetics, 108 Pfotenhauerstrasse, 01307 Dresden, Germany
2Belozersky Institute of Physico-Chemical Biology, Moscow State University, 119899 Moscow, Russia
*Correspondence: zerial@mpi-cbg.de
http://dx.doi.org/10.1016/j.chom.2013.01.008SUMMARY
Pharmacological modulators of host-microbial inter-
actions can in principle be identified using high-
content screens. However, a severe limitation of
this approach is the lack of insights into the mode
of action of compounds selected during the primary
screen. To overcome this problem, we developed a
combined experimental and computational ap-
proach. We designed a quantitative multiparametric
image-based assay to measure intracellular myco-
bacteria in primary human macrophages, screened
a chemical library containing FDA-approved drugs,
and validated three compounds for intracellular
killing of M. tuberculosis. By integrating the multi-
parametric profiles of the chemicals with those of
siRNAs from a genome-wide survey on endocytosis,
we predicted and experimentally verified that two
compounds modulate autophagy, whereas the third
accelerates endosomal progression. Our findings
demonstrate the value of integrating small molecules
and genetic screens for identifying cellular mecha-
nisms modulated by chemicals. Furthermore, selec-
tive pharmacological modulation of host trafficking
pathways can be applied to intracellular pathogens
beyond mycobacteria.
INTRODUCTION
Tuberculosis is a disease characterized by an extensive array of
interactions between mycobacteria and the host. To maintain
their intracellular niche, mycobacteria influence a variety of
fundamental host cell processes including apoptosis (Behar
et al., 2010; Chen et al., 2006; Keane et al., 2000), autophagy
(Gutierrez et al., 2004; Kumar et al., 2010), trafficking (Armstrong
and Hart, 1971; Russell, 2001), and signaling (Koul et al., 2004).
Therefore, a pharmacological modulation of the host cell mech-
anisms that are hijacked by the bacteria could, on the one hand,
be used to explore the processes altered during the infection
and, on the other hand, lead to development of anti-TB
compounds.Cell Host &Exploiting host processes to fight against infectious diseases
is currently an underexplored approach. Yet, it presents
several advantages. First, the host processes exploited by
pathogens are well studied from both a mechanistic and
a physiological perspective (Dyer et al., 2008). Second, host
kinase and phosphatase inhibitors that kill intracellular myco-
bacteria have been successfully identified, thus validating the
approach (Jayachandran et al., 2007; Jayaswal et al., 2010;
Kuijl et al., 2007). Third, it could better prevent the emergence
of drug-resistant strains (Schwegmann and Brombacher,
2008). Additionally, critical host cellular responses are con-
served across diverse mycobacterial strains, including drug-
resistant ones (Kumar et al., 2010). Given the complexity of
mycobacteria-host interactions, we reasoned that the target
space for perturbations acting upon the host could be signifi-
cantly larger than so far explored.
Since mycobacteria block phagosome maturation (Armstrong
and Hart, 1971; Pieters, 2008; Russell, 2001), a substantial target
space could be related to endosomal/phagosomal trafficking.
This could be explored by cell-based small molecule screens
monitoring intracellular mycobacterial survival. However, a
severe constraint is that the primary assay typically does not
have the resolution to provide insights into the mode of function
of the selected hits (Swinney and Anthony, 2011).
In this study, we addressed this challenge by exploiting our
knowledge of the molecular regulation of the endocytic path-
way. We recently performed a cell-based genome-wide RNAi
screen on endocytosis capturing various features of the endo-
cytic system by quantitative multiparametric image analysis
(QMPIA) (Collinet et al., 2010). The QMPIA uncovered general
principles governing endocytic trafficking that can also be
applied to the analysis of phagosome maturation. Here, we
first established a high-content assay to quantify intracellular
mycobacterial survival and screened a library of pharmacologi-
cally active compounds to identify host-specific modulators.
Second, we developed an integrated experimental and com-
putational pipeline to compare the multiparametric profiles
from the chemical screen with those from the genome-wide
siRNA screen (Collinet et al., 2010). This approach identified
chemicals capable of overpowering intracellular mycobacterial
survival by modulating the cellular trafficking processes. Our
results highlight the value of multiparametric phenotypic anal-
ysis to extract functional information from combined chemical
and genomic screens.Microbe 13, 129–142, February 13, 2013 ª2013 Elsevier Inc. 129
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High-Content Chemical Screen to IdentifyModulators of
Intracellular Mycobacteria
We developed an integrated experimental and computational
strategy for screening, selecting and validating compounds en-
dowed with antimycobacterial activity by acting on the host
machinery (Figure 1A). We first established a high-content
assay in a human primary macrophage infection model (Exper-
imental Procedures, see the Supplemental Information online).
Briefly, cells were infected with M. bovis BCG expressing
GFP (Dhandayuthapani et al., 1995) and were incubated with
chemicals for 48 hr. Since our primary interest was to identify
chemical modulators disrupting the host-mycobacteria equilib-
rium, chemicals were added after the infection. Cells were
then fixed and nuclei and cytoplasm stained and imaged using
an automated spinning disc confocal microscope. We devel-
oped further the QMPIA platform previously used to auto-
matically identify cells, endosomes, and nuclei (Collinet et al.,
2010; Rink et al., 2005) by implementing automated algo-
rithms to detect various features of intracellular bacteria and
host cell simultaneously (Figure 1B, Supplemental Information).
We screened a bioactive library (Microsource Discovery
Inc., Spectrum collection, 2,000 compounds) comprising
most FDA-approved drugs. The compounds produced repro-
ducible alterations of various parameters such as bacterial
number, intensity, and bacterial and host cell morphology
(Figure S1A).
We performed cluster analysis using an improvement of the
method previously used (Collinet et al., 2010) based on density
estimation (N.S., T. Galvez, C. Collinet, G.M., M.Z., and Y.K.,
unpublished data; Experimental Procedures). The compounds
grouped into six distinct clusters, each with a distinct pattern,
i.e., phenotypic profile (Figures 1C and 1D, Table S1). The
strength of the phenotype is given by its phenoscore. Due to
the multiparametric nature of our screening output, we expected
each cluster to capture distinct phenotypic features ofmycobac-
teria and the host. Cluster M5 (containing 115 compounds) was
of particular interest, as it was characterized by a strong reduc-
tion of bacterial parameters but relatively weak changes in host
parameters reflecting toxicity, suggesting that the compounds in
this cluster are detrimental to bacteria but not significantly toxic
to the host.
Since we aimed to identify compounds that act upon the host,
we counterselected those directly killing mycobacteria by
screening the MSD library using the alamar blue assay (see
the Experimental Procedures). Interestingly, only six com-
pounds were shared with cluster M5, suggesting that most
compounds in this cluster are not bacteriostatic. Additionally,
compounds functionally annotated as ‘‘antibacterial’’ were not
enriched in cluster M5 despite scoring in the alamar blue screen
(Figure S1B). Standard antimycobacterial drugs were not en-
riched in any particular cluster and yielded weak phenotypes
(Figures S1C–S1F, Supplemental Information). This is probably
because our cell-based assay measures the reduction in GFP
fluorescence and therefore primarily reflects modulation of lyso-
somal degradation. Thus, the compounds of cluster M5 could
modulate cellular processes at the host-pathogen interface
rather than acting directly on the bacteria.130 Cell Host & Microbe 13, 129–142, February 13, 2013 ª2013 ElseValidation of Three Compounds on M. tuberculosis
To validate the results from the screen, we selected three com-
pounds within the cluster M5, namely Nortriptyline, Prochlorper-
azine edisylate (PE), and Haloperidol (Figures 2B–2D), on
the basis of (1) amplitude of the phenotypes (Figure 2E, Fig-
ure S2A), showing reduced bacterial intensity, fewer bacteria,
and infected cells; and (2) lack of effect in the alamar blue screen.
Additionally, these compounds did not show bacteriostatic
activity on M. bovis BCG-GFP at neutral and acidic pH (Figures
S2B and S2C), or plate assay of M. tuberculosis (data not
shown).
To determine whether the phenotype observed on M. bovis
BCG-GFP was reproducible on pathogenic M. tuberculosis, we
performed a colony-forming unit (CFU) assay onM. tuberculosis
strain H37Rv and two clinical strains using the three selected
compounds and the antimycobacterial drugs Rifampin,
Rapamycin (Gutierrez et al., 2004), and H89 (Kuijl et al., 2007)
as controls. All three selected compounds caused a significant
reduction in bacterial colonies in all the strains (Figure 2F), con-
firming that they impair intracellular survival ofM. tuberculosis.
Integration of Multiparametric Chemical and Genetic
Data Sets to Identify Cellular Processes Modulated by
Compounds
Since we aimed to identify compounds restoring mycobacteria-
arrested phagosome maturation, we explored the effects of the
selected compounds onmycobacterial trafficking.We quantified
the colocalization of M. bovis BCG-GFP with lysobisphosphati-
dic acid (LBPA), a marker of late endocytic compartments (Fratti
et al., 2001; Kobayashi et al., 1998; see the Experimental Proce-
dures and Figures S2D and S2E). Infected cells treated with the
selected compounds showed significantly higher colocalization
than control cells (Figure 2G), indicating that the arrest in phag-
osome maturation was reverted.
A significant challenge in phenotypic chemical screens is to
gain insights into the mechanism of action of the selected
compounds. Multiparametric profiles are specific signatures of
either chemical or genetic perturbations because they capture
multiple facets of a biological system. Since random matches
between such profiles are unlikely, clues into the molecular
processes targeted by the chemicals could be obtained in
principle by systematically searching for genetic alterations pro-
ducing similar phenotypes. Hence, we aimed to match the multi-
parametric profiles of the compounds from the mycobacteria
screen with those of the siRNAs from the genome-wide endocy-
tosis screen (Collinet et al., 2010). However, the two screens are
not directly comparable due to their distinct characteristics, i.e.,
a chemical screen on intracellular mycobacterial survival in
human primary macrophages versus a functional genomics
screen on endocytosis in HeLa cells. To overcome this problem,
we bridged the two data sets via an intermediate screen, where
the compounds from cluster M5 were screened on the endocy-
tosis assay in HeLa cells (Figure 3A). HeLa cells were pretreated
with the compounds prior to the internalization of fluorescently
labeled epidermal growth factor (EGF) and Transferrin (Tfn) for
10 min (Collinet et al., 2010), imaged, and multiple parameters
extracted (Supplemental Information).
Density estimation-based clustering separated the com-
pounds into two subclusters, E1 and E2 (Figure 3B, Table S2),vier Inc.
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Figure 1. High-Content Image-Based Screen for Intracellular Mycobacteria Survival
(A) Flowchart of the experimental and computational pipeline used in this study.
(B) (Ba) Representative example of a human primary monocyte-derived macrophage infected with M. bovis BCG-GFP with cell contours (dashed line). (Bb)
Segmentation of macrophage: intensity distribution of nuclear and cytoplasmic regions used to draw the contours of the cell. (Bc) Segmentation of bacteria:
intensity distribution of bacteria in the region marked in the green square used for fitting the bacteria model.
(C) Heatmap representation of themycobacteria high-content chemical screen after density estimation-based clustering. Rows denote cluster IDs and number of
compounds. Columns are parameters of the high-content assay (Supplemental Information). M5 is the cluster analyzed in this study.
(D) Representative images from clusters M1–M6.
See also Figure S1 and Table S1.
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Figure 2. Validation of Three Selected Compounds for Intracellular Mycobacterial Survival
(A–D) Representative images of infected cells treated with DMSO (A), Nortriptyline (B), prochlorperazine edisylate (PE) (C), and Haloperidol (D) at a concentration
of 10 mM for 48 hr after infection. Arrowheads indicate GFP-positive structures that are identified as ‘‘bacteria’’ by the QMPIA. Scale bar, 10 mm.
(E) Quantitative multiparametric profiles of the phenotypes in (A)–(D) with the Z score (y axis) of the parameters (1–30) showing, e.g., decrease in number and
intensity of intracellular mycobacteria. Error bars represent SEM.
(F) CFU analysis of human primary monocyte-derived macrophages infected with virulentM. tuberculosis H37Rv or two different clinical isolates CS1 and CS2
and treated with the indicated compounds for 48 hr (pooled data from two independent biological replicates with at least three technical replicates each). Error
bars represent SD. D (DMSO0.01%), Rf (Rifampin 2 mM), Rp (Rapamycin, 5.5 mM), PE (Prochlorperazine edisylate, 10 mM), N (Nortriptyline, 10 mM), H (Haloperidol,
10 mM), H89 (H89, 10 mM). p values for all compounds tested (except H89) were <0.0001 and <0.01, for H37Rv and the two clinical strains, respectively.
(G) Colocalization of M. bovis BCG-GFP and LBPA in cells treated with the indicated drugs. Number of cells analyzed per condition is indicated. Error bars are
SEM. Data are representative of at least two independent experiments. Abbreviations and concentrations are as in (F). See also Figure S2.
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Figure 3. Integration of Chemical and RNAi Screen Data Sets
(A) Scheme illustrating the integration of the primary chemical (green) and RNAi (blue) screen datasets via an intermediate screen on the chemicals from
cluster M5.
(B and C) Endocytosis (B) and autophagy(C) profiles of subclusters E1 and E2 from cluster M5. The profiles are average representations of Z scores of the
individual compounds within each subcluster. Parameters are grouped into different phenotype classes.
(D and E) Dose-response curves of mean integral intensities ofM. bovis BCG-GFP (blue) and LC3 (magenta) for Nortryptyline (D) and prochlorperazine edisylate
(E). Error bars are SEM, number of images is 25, data are representative of at least two independent experiments.
(F) Summary of IC50 values calculated from curves in (D) and (E). See also Figure S3, Table S2, and Table S3.
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Killing M. tuberculosis by Targeting the Hostsuggesting that the compounds may act by at least two distinct
mechanisms. To identify them, we compared the multiparamet-
ric profiles of the subclusters E1 and E2 to the genome-wide
RNAi screen data set (Collinet et al., 2010) and identified theCell Host &sets of genes that are most likely to show similar phenotypes
(Experimental Procedures). We computed their representation
in KEGG pathways and GO terms (Table S3) and found that
‘‘mTOR regulation’’ and ‘‘regulation of autophagy and mTOR’’Microbe 13, 129–142, February 13, 2013 ª2013 Elsevier Inc. 133
Cell Host & Microbe
Killing M. tuberculosis by Targeting the Hostwere significantly enriched in the E1 (p = 1.2 3 104 and
9 3 104, respectively) but not the E2 (p = 0.15 and 0.4, respec-
tively) subcluster.
High-Content Autophagy Chemical Screen
Autophagy is a key process regulated by mTOR (Laplante and
Sabatini, 2012) and a known mediator of intracellular mycobac-
terial survival (Gutierrez et al., 2004; Kumar et al., 2010). The inte-
gration approach predicted that compounds from E1 modulate
autophagy. To test it, we treated HeLa cells with the compounds,
immunostained for the autophagosome marker LC3, and
extracted multiple parameters reporting diverse facets of auto-
phagosomes (Supplemental Information). The compounds of
subcluster E1, but not E2, had a strong effect on autophagy
(Figure 3C, Figure S3A), thus validating the prediction from the
integration analysis. Of the three compounds validated in intra-
cellular mycobacterial killing, Nortriptyline and PE belong to
subcluster E1, whereas Haloperidol belongs to E2. Consistent
with the data of Figure 3C, Nortriptyline and PE, similar to Rapa-
mycin or serum starvation (by HBSS), showed a strong effect on
autophagy, whereas Haloperidol did not (Figures S3B and S3C).
Human primary macrophages treated with Nortriptyline and PE
resembled HeLa cells in showing an increase in both number
and integral intensity of LC3 vesicles (Figures S3D and S3E),
indicating that their effect of increasing autophagosomes is not
cell-type restricted.
To determine whether the accumulation of autophagosomes
is related to intracellular mycobacterial killing by Nortriptyline
and PE, we first computed their IC50 values in the two assays.
For both compounds, the IC50 values for increased LC3 integral
intensity correlated well with decreased M. bovis BCG-GFP
(Figures 3D–3F), arguing that the two phenotypes are linked.
Second, if autophagy modulation were involved in intracellular
mycobacterial killing, we should visualize mycobacteria within
autophagosomes. To test this, we analyzed mycobacteria-
infected cells by electron microscopy. Whereas in control cells
mycobacteria resided within single-membrane phagosomes
(Figure 4A), cells treated with Nortriptyline and PE clearly
showed the presence of mycobacteria within autophagosomes,
defined as vesicles containing multiple membrane whorls
and delimited by double membrane (Figures 4B–4F). Haloper-
idol-treated cells, as expected, did not show this effect
(Figure S4A). Finally, we tested the effect of an inhibitor of auto-
phagy, 3-methyladenine (3MA) (Seglen andGordon, 1982). Upon
treatment with Nortriptyline and PE in the presence of 3-MA,
mycobacteria were observed not in autophagosomes but in
phagosomes (Figures S4B–S4D). Additionally, 3-MA reverted
the effect of Nortriptyline on mycobacterial survival in both
CFU and image-based assays (data not shown), arguing that
the effect of the compounds on mycobacteria is related to
autophagy.
Nortriptyline and PE Modulate Autophagy by Different
Mechanisms
Autophagy is a multistep process consisting of autophagosome
formation, maturation, and eventual degradation by fusion with
lysosomes (autophagolysosomes). The increase in autophago-
somes mediated by Nortriptyline and PE could be due to either
a higher rate of formation or a block in maturation and degrada-134 Cell Host & Microbe 13, 129–142, February 13, 2013 ª2013 Elsetion (autophagic flux) (Klionsky et al., 2008). To distinguish
between these possibilities, we used two approaches. First,
we tested whether blockers of lysosomal degradation, e.g.,
inhibitors of acidification (BafilomycinA1 or Chloroquine) that
inhibit autophagic flux, had an additive effect with the com-
pounds on autophagosome accumulation (Klionsky et al.,
2008). HeLa cells were treated with Nortriptyline and PE in the
presence or absence of BafilomycinA1, and LC3 lipidation
(LC3-II band) was assessed by immunoblotting. Whereas both
Nortriptyline and PE showed significant increase in the LC3-II
band, additive effects of BafilomycinA1 were seen only upon
Nortriptyline, but not PE, treatment (Figure S5A). In addition,
we generated HeLa cells stably expressing LC3 fused to GFP
under the control of the endogenous promoter through BAC re-
combineering (HeLa BAC LC3-GFP; Poser et al., 2008). The
results (Figures S5B and S5C) confirmed that Nortriptyline, but
not PE, had an additive effect with BafilomycinA1 and Chloro-
quine in increasing LC3-GFP vesicles.
Second, we used an established assay for measuring auto-
phagic flux based on a tandem mRFP-GFP-LC3 construct
(Kimura et al., 2007). Since GFP is quenched in the acidic envi-
ronment of autophagolysosomes whereas mRFP remains
stable, a block in autophagy flux results in higher colocalization
of mRFP and GFP compared to induction of autophagy. HeLa
cells stably expressing mRFP-GFP-LC3 (Settembre et al.,
2011) were treated with the compounds, and the colocalization
between mRFP and GFP was quantified. Nortriptyline, similar
to starvation-induced autophagy (HBSS), showed a low mRFP
to GFP colocalization, whereas PE, similar to BafilomycinA1
and Chloroquine, yielded higher colocalization (Figures 5A and
5B). Similar results were obtained for the colocalization of LC3-
GFP with LBPA in HeLa-LC3-GFP cells (Figure S5D). Based on
previous studies (Klionsky et al., 2008), these results can be in-
terpreted as indicating that Nortriptyline induces autophagy
whereas PE inhibits autophagic flux.
In principle, blockers of autophagy flux should not have a detri-
mental effect on mycobacteria. Indeed, inhibitors of autophagy
flux that abrogate the function of lysosomes by blocking acidifi-
cation did not affect the intensity of intracellular M. bovis
BCG-GFP (Figure S5E). In order to determine whether PE has
a similar effect on lysosomal pH, we quantified the intensity of
the acidotropic dye Lysotracker red over time. Unlike classical
blockers of autophagy flux, PE did not have a negative effect
on the acidity of lysosomes, but quite the contrary, it significantly
increased it (Figure 5C). Moreover, this effect correlated with the
presence of mycobacteria within the lysotracker red-positive
vesicles (Figure 5C) and a concomitant reduction in bacterial
intensity (Figure 5D).
The increased acidification by PE is in apparent contradiction
with the inhibition of autophagic flux. To solve this discrepancy,
we treated HeLa cells stably expressing mRFP-GFP-LC3 with
the compounds for different periods of time. If autophagy flux
were completely blocked, the colocalization between mRFP
and GFP (corresponding to nonacidic autophagosomes) should
increase with time, whereas if the flux were slowed down, then
the colocalization would be expected to decrease (i.e., autopha-
gosomes become acidic). The colocalization of mRFP and GFP
increased over time in cells treated with BafilomycinA1 (Fig-
ure 5E) or Chloroquine (data not shown). In contrast, invier Inc.
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Figure 4. Ultrastructural Analysis of Autophagy and Intracellular Mycobacterial Survival
(A–C) Electronmicrographs ofM. bovisBCG-GFP-infected human primarymonocyte-derivedmacrophages treatedwith DMSO (A), 10 mMN (B), or PE (C) for 4 hr.
Black arrows indicate mycobacterial phagosomes, and black and white arrowheads indicate autophagosomes with and without mycobacteria, respectively.
Mitochondria (Mi), nucleus (Nuc), mycobacterial phagosome (MP), autophagosomes (AP), mycobacteria containing autophagosome (MAP).
(D–F) Quantification of number of autophagosomes (D) (n = 30), autophagosome area as percentage of total cell area (E) and total cell area (F) (n = 6) from the
electronmicrographs. D (DMSO, 0.01%), N (Nortriptyline, 10 mM), PE (Prochlorperazine edisylate, 10 mM). Numbers denote p values in comparison to DMSO. See
also Figure S4.
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Figure 5. Nortriptyline and PE Modulate Autophagy Differently
(A) Representative images of HeLa cells stably expressing mRFP-GFP-LC3 treated with the indicated chemicals for 2 hr. DAPI/CMB denotes the cell nucleus and
cytoplasm. Scale bar, 10 mm.
(B) Quantification of colocalization between themRFP andGFP signals. The number of cells analyzed per condition is indicated. Results are representative of four
experiments. Error bars are SEM. Abbreviations and concentrations are as in (A).
(C and D) Quantification of integral intensity of lysotracker red-labeled vesicles (C) and M. bovis BCG-GFP (D) in infected human primary macrophages treated
with either DMSO or PE (10 mM) for the indicated periods of time. Total and bacterial LTR refer to integral intensity of all acidic compartments and those containing
bacteria, respectively. Data are averaged from 45 images/condition/time point and normalized to DMSO to represent fold change (representative of two
independent experiments).
(E) Colocalization between the mRFP and GFP signals in HeLa cells stably expressing mRFP-GFP-LC3 treated with the indicated drugs for different periods
of time. Colocalization at a single threshold of 0.35 was used to generate the time response curves. Data are from 50 images per condition and from four
experiments. For (A), (B), and (E), D (DMSO, 0.01%), Hb (HBSS), N (Nortriptyline,10 mM), ChQ (Chloroquine, 25 mM), Baf (BafilomycinA1, 100 nM), PE
(10 mM).
(F) Mean integral intensity ofM. bovis BCG-GFP upon treatment of infected human primary macrophages with different concentrations of IFN-g for 4 hr prior to
treatment with either 1 mM or 10 mMN or PE, for 48 hr. Significance was calculated by Student’s t test. NS p > 0.05, *p < 0.05, **p < 0.001, ***p < 0.0001. Data are
averaged from 16 images/condition and are representative of four experiments. For (B)–(F), error bars indicate SEM. See also Figure S5.
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but then progressively decreased (Figure 5E), showing that the
autophagosomes acidify over time.
To further characterize the effects of Nortriptyline and PE on
autophagy, we tested whether they could synergize with an es-
tablished physiological inducer of autophagy, Interferon-gamma
(IFN-g) (Gutierrez et al., 2004; Matsuzawa et al., 2012). We
preactivated infected cells with IFN-g and assessed the effect
of the compound addition on mycobacterial survival. The results
were striking (Figure 5F) and showed that Nortriptyline
synergized strongly with IFN-g, supporting its role in autophagy136 Cell Host & Microbe 13, 129–142, February 13, 2013 ª2013 Elseinduction. PE instead exerted a much weaker effect, providing
additional evidence that the two compounds interact differently
with the autophagy machinery.
Haloperidol Accelerates Endolysosomal Trafficking
Haloperidol kills intracellular mycobacteria by a mechanism
distinct from autophagy. Haloperidol belongs to subcluster E2
(Figure 3B). This subcluster is characterized by a strong alter-
ation of the endocytic profile exemplified by an increase in
EGF and Tfn content, increased colocalization of EGF to Tfn
(reduced sorting), and accumulation of EGF in large endosomesvier Inc.
C D
E
BA Figure 6. Analysis of Endocytosis Traf-
ficking by Haloperidol
(A and B) The kinetics of endocytic trafficking were
quantified using a cell-based LDL trafficking
assay. (A) Integral intensity of LDL in early endo-
somes and (B) late endosomes. Values are H
treatment (10 mM) subtracted from DMSO and
derived from an average of 1,200 cells/time point.
Error bars are SEM of number of images (average
of 40 per condition). Data are representative of two
experiments.
(C and D) A431 cells stably expressing Rab5-GFP
were treated with either DMSO or Haloperidol
(10 mM) for 2 hr and imaged live. Velocities of
minus-end (toward cell center) (C) and plus-end-
directed movement (away from cell center) are
shown for DMSO-treated cells (black line) and
H-treated cells (green line). For curves in (B)–(D),
the p value is for points denoted by asterisks (see
the Experimental Procedures). For (C) and (D),
error bars are standard deviations, n = 37 (DMSO),
n = 29 (H).
(E) Mean square displacement curves for the
movies (Figures 6C and 6D) were computed as
described in the Experimental Procedures. The
second part of the biphasic curve indicating long
timescalemovements was fitted using linear least-
square fit. Diffusion coefficient is derived from the
slope of the fitted curves. See also Figure S6,
Movie S1, and Movie S2.
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endocytic system (Collinet et al., 2010; Rink et al., 2005), the
alterations observed argue for a faster degradation. Hence, we
hypothesized that Haloperidol could positively modulate endo-
cytic trafficking along the degradative route. To test this hypoth-
esis, we monitored the kinetics of transport of low-density
lipoprotein (LDL) from early to late endosomes, using Rab5
(Bucci et al., 1992) and LBPA (Kobayashi et al., 1998) asmarkers,
respectively (Figure S6A). HeLa cells stably expressing GFP-
Rab5 from the endogenous promoter (HeLa BAC GFP-Rab5c)
(Foret et al., 2012) were treated with Haloperidol and allowed
to internalize LDL for different times prior to immunostaining
with anti-Apolipoprotein B (ApoB) (to detect LDL) and LBPA anti-
bodies. Haloperidol significantly increased the intensity of LDL in
late, but not early, endosomes (Figures 6A and 6B). Similarly,
LDL-containing late, but not early, endosomes were larger,
more numerous, and closer to the cell center in Haloperidol-
treated compared to control cells (Figures S6B–S6G). TheseCell Host & Microbe 13, 129–142,results confirm the prediction that Halo-
peridol leads to acceleration of trafficking
along the degradative pathway.
Phagosome maturation depends on
the fusion with early, late endosomes
and lysosomes (Desjardins et al., 1994;
Fairn and Grinstein, 2012) and is regu-
lated by the motility of endocytic organ-
elles along the cytoskeleton and the
recruitment of the membrane tethering
fusion machinery. Both processes could
be enhanced by Haloperidol. We firsttested the influence of Haloperidol on endosome motility.
Increasing concentration of Rab5 and displacement of early en-
dosomes toward cell center are predictive of progression from
early to late endosomes (Del Conte-Zerial et al., 2008; Rink
et al., 2005). We therefore quantified endosome motility in cells
stably expressing GFP-Rab5, as previously described (Rink
et al., 2005) (Movie S1 andMovie S2), and computed the velocity
toward the cell center (minus end microtubule directed) and
periphery (plus end) as a function of GFP-Rab5 intensity. Halo-
peridol-treated cells showed a much higher motility of early en-
dosomes harboring high levels of Rab5, and this enhancement
was higher toward the cell center (Figures 6C and 6D). Next,
we computed the mean square displacement of endosomes
over time, an established way to characterize motility patterns
(Caspi et al., 2002). In Haloperidol-treated cells, long, but not
short, timescale movements of GFP-Rab5 endosomes were
significantly accelerated (Figure 6E). Thus, Haloperidol acceler-
ates the centripetal movement of early endosomes.February 13, 2013 ª2013 Elsevier Inc. 137
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Figure 7. Haloperidol Induces Alterations in Intracellular Mycobacterial Trafficking
(A and C) Representative images of M. bovis BCG-GFP-infected human primary macrophages treated with 10 mM Haloperidol for the indicated times and
immunostained for EEA1 (A) and LBPA (C). The outline of infected cells is shown in dashed lines. Scale bar, 10 mm. The presence of EEA1 and LBPA on
mycobacterial phagosome, as indicated by arrows and arrowheads (at 20 min), respectively, is mutually exclusive.
(B and D) Quantification of colocalization of M. bovis BCG-GFP with EEA1 (B) and LBPA (D). A stringency threshold of 0.35 was used. Data are averaged from
about 1,000 infected cells and are representative of at least two independent experiments. Error bars are SEM. The p value denotes significance for the
consecutive points of the time series denoted by asterisks (see the Experimental Procedures).
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Killing M. tuberculosis by Targeting the HostSecond, we tested whether Haloperidol could lead to
increased delivery of the membrane-tethering and fusion
machinery to the arrested mycobacterial phagosome. Myco-
bacterial phagosomes contain Rab5, but not Rab7 (Alix et al.,
2011; Russell, 2001), and lack PI(3)P (Vergne et al., 2005),
which mediates the recruitment of various Rab5 effectors,
including the membrane tethering factor early endosomal
antigen 1 (EEA1) (Christoforidis et al., 1999). Therefore, myco-
bacterial phagosomes lack EEA1 (Fratti et al., 2001). If Haloper-
idol could restore such machinery, one would expect to see
a small, transient increase in EEA1 on mycobacterial phago-
somes. We treated M. bovis BCG-infected cells with Haloper-
idol for different times and quantified the colocalization of
mycobacteria with EEA1 and LBPA. Whereas in control cells,
as expected, mycobacterial phagosomes were devoid of
EEA1 at all times (Figure 7A, upper panels; Figure 7B), in Halo-
peridol-treated cells a small but significant fraction of EEA1
localized to mycobacterial phagosomes 20–30 min posttreat-
ment (Figure 7A, lower panels; Figure 7B). Such an effect was
specific for Haloperidol, as it was not observed in cells treated
with Nortriptyline and PE (data not shown). Moreover, in Halo-
peridol-treated cells the colocalization of mycobacteria and
LBPA increased with time (Figures 7C and 7D). Altogether,
these data indicate that Haloperidol restores the delivery of crit-
ical components of the membrane-tethering machinery to the
mycobacterial phagosomes, thereby delivering mycobacteria
to lysosomes.138 Cell Host & Microbe 13, 129–142, February 13, 2013 ª2013 ElseDISCUSSION
In this study, we developed a pipeline of experimental and
computational methods to identify pharmacological modulators
of host cellular processes that trigger killing of intracellular myco-
bacteria. First, we established a multiparametric image-based
assay to quantify mycobacterial survival in human primary
macrophages. Second, we used a pharmacological approach
to disrupt the host-pathogen equilibrium in favor of the host.
Third, we developed computational methods to compare the
multiparametric profiles of chemicals with those of siRNAs, to
identify the cellular mechanisms underlying the antibacterial
activities of the compounds. Fourth, we validated the predictions
from such comparison on the three selected compounds and es-
tablished that two of them modulate autophagy via distinct
mechanisms and the third one accelerates endocytic trafficking.
Our results demonstrate the predictive value of comparing quan-
titative multiparametric profiles from chemical and genetic
screens to decipher the cellular mechanisms of chemical action.
They further show that trafficking pathways can be modulated
pharmacologically to stimulate intracellular mycobacteria killing.
The key feature of our intracellular mycobacterial survival
assay is the multiplicity and reliability of parameters capturing
various features of bacteria and host at high resolution. Interest-
ingly, most compounds in the selected hit cluster (M5) are not
directly antimycobacterial. Although we cannot rule out
completely the possibility that the compounds may kill bacteriavier Inc.
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Killing M. tuberculosis by Targeting the Hostdirectly within infected cells, we favor the interpretation that they
act by modulating the host for the following reasons. First, the
M5 cluster showed very little overlap with the compounds which
act directly on bacteria. Second, the three selected compounds
do not kill mycobacteria outside the host cell under the different
conditions tested. Third, they show similar effects on uninfected
cells. Fourth, the effect of Nortriptyline and PE can be reverted by
inhibiting a host cellular process (autophagy). Fifth, Nortriptyline
showed strong phenotypic correlation with a structural analog,
Amitriptyline, in mycobacteria as well as endocytosis and auto-
phagy screens. Here, only structural analogs having a Tanimoto
distance >0.9 were considered (Supplemental Information and
Figures S2F–S2I). Sixth, Nortriptyline and PE enhance the acidity
of lysosomes. This correlates with delivery of mycobacteria to
lysosomes and their survival. Additionally, standard antimyco-
bacterial drugs showed weaker phenotypes compared to the
selected compounds. Most likely, this is because our assay
measures GFP fluorescence from mycobacteria that decays at
different rates, depending on whether the host degradation
machinery can be accelerated or not. In support of this, Rifam-
picin did not show enhanced lysosomal acidity. Thus, our
screening platform has a bias for compounds that boost host
mechanisms. Importantly, our data argue that such compounds
are likely to be missed in a screen for antimycobacterial
compounds outside the context of infected cells.
Whereas cell-based high-content screens have several
advantages over traditional target-based HT screens, under-
standing the mechanism of action of the identified compounds
is a critical bottleneck (Swinney and Anthony, 2011). One
possible approach is to identify genes that when silenced
produce a phenotype similar to that of small inhibitory molecules
(Eggert et al., 2004). However, there are significant caveats to
this approach: for example, small molecules usually act rapidly,
whereas RNAi is gradual and requires longer times, possibly
allowing the system to adapt to a new steady state. Moreover,
the biological activity of small molecules may result from the
modulation of multiple targets (Imming et al., 2006) rather than
specific ones as in RNAi, excluding off-target effects. We
reasoned that although it may prove difficult to identify targets
of small molecules by comparing the phenotypic profiles of
chemicals and silenced genes, this approach may nevertheless
allow the identification of the cellular pathways affected, as long
as the phenotypes are described with sufficient detail and spec-
ificity. Therefore, we captured the phenotypes through QMPIA,
and, by integrating chemical and functional genomics data
sets, we differentiated hit compounds of the mycobacteria
screen into distinct groups on the basis of their phenotypes on
endocytosis. Using this strategy, we could show both computa-
tionally and experimentally that one of the groups is significantly
enriched for modulators of autophagy, a well-known antimyco-
bacterial cell-defense mechanism (Gutierrez et al., 2004; Kumar
et al., 2010). Remarkably, autophagy phenotypes could thus be
identified using a general endocytosis assay.
Nortriptyline and PE influence autophagy differently. Whereas
Nortriptyline induces the formation of autophagosomes, PE
slows down autophagic flux. The basal rate of autophagy may
be sufficient to accumulate autophagosomes in the presence
of PE. These autophagosomes progressively acidify over time
and become competent for mycobacteria degradation (PonpuakCell Host &et al., 2010). PE may act at different stages, e.g., on the fusion
with lysosomes. Detailed characterization of the interactions of
Nortriptyline and PE with the autophagy machinery will lead to
a more precise understanding of their mode of action.
The identification of Haloperidol as an antimycobacterial
compound provides proof of principle for the pharmacological
modulation of endocytic trafficking as a means of boosting the
host defense system to clear intracellular pathogens. Most
importantly, our data imply that such an approach is feasible
without inducing overt toxicity to cells. Haloperidol leads to
faster degradation of cargo by accelerating transport from early
to late endocytic compartments. Previous work has identified
both general design principles and molecular details of the
machinery underlying endosome biogenesis and progression
that are relevant to the pharmacological properties of Haloper-
idol. First, transport of cargo (LDL) along the degradative route
entails a conversion from Rab5- to Rab7-positive endosomes
(Rink et al., 2005). Such conversion is based on a cut-out switch
(Del Conte-Zerial et al., 2008) that requires the endosomal levels
of Rab5 to pass a threshold value prior to triggering a feedback
loop causing its removal and substitutionwith Rab7. Second, our
recent systems survey on endocytosis has revealed that the
centripetal movement of endosomes previously observed by
quantitative live-cell imaging (Rink et al., 2005) is a master
parameter that regulates several other properties of the early en-
dosome network, including cargo progression (Collinet et al.,
2010). Mycobacterium interferes with such a switch, keeping
the phagosome in an arrested state. Remarkably, Haloperidol
exerts a positive influence on both centripetal movement of en-
dosomes and membrane recruitment of the Rab5 machinery.
By shifting the molecular composition of the mycobacterial
phagosome, Haloperidol counteracts the fine balance between
phagosome activity and maturation arrest, restoring maturation.
Thus, relatively subtle alterations in the general endocytic traf-
ficking machinery are sufficient to cause dramatic effects on
intracellular mycobacterial survival.
Our results revealed antimycobacterial properties for three ex-
isting drugs. While Nortriptyline is an antidepressant, PE and
Haloperidol are antipsychotics. The serum concentrations
achieved in patients for these drugs are lower than the in vitro
antibacterial IC50 (Regenthal et al., 1999). In principle, they would
have to be made significantly more potent or achieve signifi-
cantly higher serum levels to be effective in antimycobacterial
therapy. However, it is difficult to compare the effectiveness of
the drugs under the particular conditions used in vitro with their
pharmacokinetics properties in patients, and further studies are
necessary to corroborate their antimycobacterial activity in vivo.
Nevertheless, our work demonstrates that it is possible to find
existing compounds with previously unrecognized antimyco-
bacterial activity and mode of action. Interestingly, PE is also
used as antiemetic and administered in patients with MDR-TB
to alleviate ancillary symptoms of nausea and vomiting (Shubin
et al., 1958). The finding that three neuromodulators are en-
dowed with membrane trafficking and antimycobacterial activity
suggests that compounds can exert diverse biological effects
depending on the cellular context analyzed. Such influences
are typically neglected in target-based screenings. Repurposing
existing drugs for additional applications could thus open new
avenues and lead to rapid therapeutic advances (Huang et al.,Microbe 13, 129–142, February 13, 2013 ª2013 Elsevier Inc. 139
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Killing M. tuberculosis by Targeting the Host2011). However, it is not excluded that the effects on intracellular
transport highlighted in this study may even be part of the mech-
anism of action of the compounds in neuromodulation. The
mechanistic clues obtained here open the possibility of exploring
the role of cellular processes, i.e., autophagy and modulation of
endocytic trafficking, in the context of their original therapeutic
use. Indeed, many tricyclic antidepressants, regarded as medi-
ators of neurotransmitter signaling, show significant effects on
autophagy (Rossi et al., 2009; Zschocke et al., 2011). Synergistic
activities of such compounds with other antibacterial and
immune modulators, such as IFN-g, could be exploited to yield
more potent pharmacological interventions. Finally, the methods
described here can be adapted to other diseases where host cell
processes need to be targeted. The compounds identified may
therefore also be effective against pathogens using similar
survival strategies.
EXPERIMENTAL PROCEDURES
High-Content Screen for Intracellular Mycobacteria Survival
Human primary monocyte-derived macrophages were infected with M. bovis
BCG-GFP for 1 hr at moi of 1:10, washed extensively (Biotec EL406). After
adding the compounds (10 mM) (Beckman Fxp automatic workstation), cells
were incubated for 48 hr, fixed with 3.7% PFA (Sigma), stained with 1 mg/ml
DAPI and 3 mg/ml Cell Mask Blue (Invitrogen), and imaged using the automated
spinning disk confocal Opera (Perkin Elmer). See the Supplemental Informa-
tion for details.
Data Analysis: Density-Based Clustering
Multiparametric profiles from the chemical screen were clustered using
density-based clustering algorithm with von Mises-Fisher kernel used for
density estimate (N.S., T. Galvez, C. Collinet, G.M., M.Z., and Y.K., unpub-
lished data). Clustering was performed varying the kernel concentration
parameter k. For every data set, the number of clusters obtained stabilized
within a k range of 10–150. Further increase of k would not lead to an increase
in the number of clusters. For each data set, a cluster wasmanually selected at
the first value of k that produced clusters that were stable in number and size.
k values for the mycobacteria and endocytosis screens were 30 and 90,
respectively.
Integrating Chemical and Genetic Screens
Representative profiles of the two endocytosis subclusters were generated by
averaging the profiles of individual compounds in each subcluster. For these
two profiles, we assembled a list of genes from the endocytosis screen (Colli-
net et al., 2010) that had a Phenoscore >0.95 and a Pearson correlation of 0.7.
These lists were subjected to gene annotation enrichment analysis using
a standard hypergeometric test. Gene annotations were obtained from Gene
Ontology and KEGG Pathway databases.
Intracellular Mycobacterial Trafficking Assay
Human primary monocyte-derived macrophages were infected with M. bovis
BCG-GFP and stained for lysotracker red or LBPA as markers of late
endosomes and lysosomes (Kobayashi et al., 1998; Schmid and Cullis,
1998). Colocalizations were scored over a range of stringency thresholds
varying from 0 (most relaxed) to 1 (most stringent).
Alamar Blue Screen for Antibacterial Compounds
To mid-log phase M. bovis BCG-GFP seeded into 384-well plates (OD600 =
0.03) in a volume of 90 ml 7H9, compounds were added to a final concentration
of 10 mM. DMSO and Amikacin (200 mg/ml) were included as negative and
positive controls, respectively. Plates were incubated at 37C for 4 days, fol-
lowed by addition of 10 ml of 1:1 mix of alamar blue (serotec) and 10%
Tween-80. After 24 hr at 37C, fluorescence was read in the Tecan Pro (Ex
535 nm; Em 590 nm). Analysis was done per plate. Compounds with a Z140 Cell Host & Microbe 13, 129–142, February 13, 2013 ª2013 Elsescore >3 were considered hits. The screen was repeated twice (Z0 factors
are 0.85 and 0.9 for each run). Hits from both runs were combined.
High-Content Autophagy Assay
HeLa cells were treated with the compounds at a final concentration of 10 mM,
incubated for 4 hr, fixed with 3.7% PFA, and immunostained with anti-LC3
antibody (clone PM036, MBL Labs). Cells were counterstained by DAPI and
Cell Mask blue, imaged, and analyzed as described above.
Dose-Response Curves
To calculate IC50 for mycobacterial survival, human primarymonocyte-derived
macrophages were infected with M. bovis BCG-GFP, treated with different
concentrations of the compounds for 48 hr, and fixed. For autophagy assay,
the same preparation of cells was treated with the compounds for 2 hr, fixed,
and immunostained for LC3. Cells were imaged and analyzed as described.
M. tuberculosis CFU Assay
Human primarymacrophageswere infectedwith virulentM. tuberculosis strain
H37Rv and two different clinical isolates (CS1 and CS2) for 1 hr at moi 1:10,
washed, treated with Amikacin (200 mg/ml) for 45 min, washed again, and
treated with the compounds. Cells were lysed after 48 hr with 0.05% SDS
and plated in multiple dilutions on 7H11 agar plates. Colonies were counted
after incubation at 37C for 3 weeks.
Electron Microscopy
Cells were fixed with 2.5% glutaraldehyde followed by postfixation in ferrocy-
anide-reduced osmium following standard protocols (Karnovsky, 1971)
and embedded with epon. Then 70 nm thin sections were cut on a Leica ultra-
microtome, stained with uranyl acetate and lead citrate following classical
procedures, and imaged on a 100 kV Tecnai 12 TEM microscope. For area
measurements, several overlapping high-magnification images covering the
whole cell were acquired, and a montage was generated using ImageJ.
Live-Cell Imaging
A431 cells stably expressing GFP-Rab5 were treated with 10 mM Haloperidol
for 2 hr and imaged live using Zeiss Duo scan microscope at 0.098 s/frame for
2 min. Individual endosomes were identified and tracked over time as
described (Rink et al., 2005). To calculate mean square displacement, endoso-
mal trackswere first iteratively divided into nonoverlapping equal time intervals
from 0.1 to 70 s, and their displacements were computed for each interval.
Next, the square of displacement for all endosomal tracks for a given condition
was averaged and plotted as a function of the time interval. In such a curve,
early endosomes show a characteristic biphasic behavior, which we refer to
as short timescale and long timescale movements.
Estimation of p Value for Time Series
The null hypothesis tested is that deviation of a sequence of Nmeasurements
from zero is the result of normally distributed noise. Given that every measure-
ment i in the series has a valueDi and variance s
2
i , we computed the probability
of the null hypothesis (p value) as
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